Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression

Journal of Infectious Diseases

Volumn 179, Issue 1, 1999, Pages 83-91

  Amiel, Corinne ^b   Darcissac, Edith ^b   Truong, Marie José ^b   Dewulf, Joelle ^b   Loyens, Marc ^b   Mouton, Yves ^b   Capron, André ^b   Bahr, George M ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; INTERLEUKIN 10; INTERLEUKIN 16; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; RECOMBINANT INTERLEUKIN 16; UNCLASSIFIED DRUG; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CASE-CONTROL STUDIES; CYTOKINES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-16; LEUKOCYTES, MONONUCLEAR; RECOMBINANT PROTEINS; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 0013603751     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314550     Document Type: Article

References (39)

1. Baier M, Bannert N, Werner A, Lang K, Kurth R. Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor. Proc Natl Acad Sci USA 1997;94:5273-7.
2. Cruikshank WW, Center DM, Nisar N, et al. Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression. Proc Natl Acad Sci USA 1994;91:5109-13.
3. Baier M, Werner A, Bannert N, Metzner K, Kurth R. HIV suppression by interleukin-16. Nature 1995;378:563.
4. Idziorek T, Khalife J, Billaut-Mulot O, et al. Recombinant human IL-16 inhibits HIV-1 replication and protects against activation-induced cell death (AICD). Clin Exp Immunol 1998;112:84-91.
5. Center DM, Kornfeld H, Cruikshank WW. Interleukin 16 and its function as a CD4 ligand. Immunol Today 1996;17:476-81.
6. Mackewicz CE, Levy JA, Cruikshank WW, Kornfeld H, Center DM. Role of IL-16 in HIV replication. Nature 1996;383:488-9.
7. Maciaszek JW, Parada NA, Cruikshank WW, Center DM, Kornfeld H, Viglianti GA. IL-16 represses HIV-1 promoter activity. J Immunol 1997;158:5-8.
8. Benkirane MD, Corbeau P, Housse TV, Deveaux C. An antibody that binds the immunoglobulin CDR3-like region of the CD4 molecule inhibits provirus transcription in HIV-infected T cells. EMBO J 1993;12:4909-12.
9. Tremblay M, Meloche S, Gratton S, Wainberg MA, Sekaly RP. Association of p56-1ck with the cytoplasmic domain of CD4 modulates HIV-1 expression. EMBO J 1994;13:774-83.
10. Than S, Oyaizu N, Tetali S, Romano J, Kaplan M, Pahwa S. Upregulation of human immunodeficiency virus (HIV) replication by CD4 cross-linking in peripheral blood mononuclear cells of HIV-infected adults. J Virol 1997;71:6230-2.
11. + T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous β-chemokines and the viral inductive effects of other endogenous cytokines. Proc Natl Acad Sci USA 1996;93:14076-81.
12. Zanussi S, D'Andrea M, Simonelli C, Tirelli U, De Paoli P. Serum levels of RANTES and MIP-1α in HIV-positive long-term survivors and progressor patients. AIDS 1996;10:1431-50.
13. McKenzie SW, Dallalio G, North M, Frame P, Means RT Jr. Serum chemokine levels in patients with non-progressing HIV infection. AIDS 1996;10:F29-33.
14. Weiss L, Si-Mohamed A, Giral P, et al. Plasma levels of monocyte chemoattractant protein-1 but not those of macrophage inflammatory protein-1α and RANTES correlate with virus load in human immunodeficiency virus infection. J Infect Dis 1997;176:1621-4.
15. Bisset LR, Rothen M, Joller-Jemelka HI, Dubs RW, Grob PJ, Opravil M. Change in circulating levels of the chemokines macrophage inflammatory proteins 1α and 1β, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir. AIDS 1997;11:485-91.
16. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 1993;269:729-30.
17. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994;32:292-300.
18. Piatak M Jr, Luk KC, Williams B, Lifson JD. Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. Biotechniques 1993;14:70-80.
19. Neumann M, Harrison J, Saltarelli M, et al. Splicing variability in HIV type 1 revealed by quantitative RNA polymerase chain reaction. AIDS Res Hum Retroviruses 1994;10:1531-42.
20. Legoux P, Minty C, Delpech B, Minty AJ, Shire D. Simultaneous quantitation of cytokine mRNAs in interleukin-1β stimulated U373 human astrocytoma cells by a polymerisation chain reaction method involving coamplification with an internal multi-specific control. Eur Cytokine Netw 1992;3:553-63.
21. Olivares I, Shaw G, Lopez-Galindez C. Phenotypic switch in a Spanish HIV type 1 isolate on serial passage on MT-4 cells. Aids Res Hum Retroviruses 1997;13:979-84.
22. + cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression. Nature Med 1997;3:659-64.
23. Gao M, Tsuchie H, Detorio MA, et al. Interleukin-16 does not suppress HIV-1 replication in naturally infected peripheral blood mononuclear cells. AIDS 1997;11:538-9.
24. Ginaldi L, De Martinis M, D'Ostilio A, Di Gennaro A, Marini L, Quaglino D. Altered lymphocyte antigen expressions in HIV infection: a study by quantitative flow cytometry. Am J Clin Pathol 1997;108:585-92.
25. Viglianti GA, Parada NA, Maciaszek JW, Kornfeld H, Center DM, Cruikshank WW. IL-16 anti-HIV-1 therapy. Nature Med 1997;3:938.
26. + subjects. J Clin Invest 1997;100:2737-43.
27. Oyaizu N, McCloskey TW, Than S, Hu R, Kalyanaraman V, Pahwa S. Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-γ and tumor necrosis factor-α secretion. Blood 1994;84:2622-31.
28. + T cells. Blood 1997;90:1588-93.
29. Baldari CT, Milia E, Di Somma MM, Baldoni F, Valitutti S, Telford JL. Distinct signalling properties identify different CD4 epitopes. Eur J Immunol 1995;25:1843-50.
30. + T cells. Proc Natl Acad Sci USA 1996;93:11014-8.
31. Banda NK, Bernier J, Kurahara DK, et al. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 1992;176:1099-106.
32. + T-cell mediated suppression of HIV-1 long terminal repeat-driven gene expression is not modulated by the CC chemokines RANTES, macrophage inflammatory protein (MIP)-1α and MIP-1β. AIDS 1997;11:575-80.
33. Garzino-Demo A, Arya SK, Devico AL, Cocchi F, Lusso P, Gallo RC. C-C chemokine RANTES and HIV long terminal repeat-driven gene expression. Aids Res Hum Retroviruses 1997;13:1367-71.
34. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-73.
35. Deng H, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381:661-6.
36. Ullum H, Cozzi Lepri A, Victor J, et al. Production of β-chemokines in human immunodeficiency virus (HIV) infection: evidence that high levels of macrophage inflammatory protein-1β are associated with a decreased risk of HIV disease progression. J Infect Dis 1998;177:331-6.
37. Scala E, D'Offizi G, Rosso R, et al. C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection. J Immunol 1997;158:4485-92.
38. Zhang Y, Center DM, Wu DMH, et al. Processing and activation of prointerleukin-16 by caspase-3. J Biol Chem 1998;273:1144-9.
39. + T cells by IL-16 and IL-2. J Immunol 1998;160:2115-20.